SFM
VYGR icon

Sphera Funds Management’s Voyager Therapeutics VYGR Stock Holding History

Sphera Funds Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.81M Buy
469,761
+130,000
+38% +$512K 0.29% 82
2025
Q4 		$1.34M Buy
339,761
+140,000
+70% +$619K 0.26% 83
2025
Q3 		$933K Buy
+199,761
New +$723K 0.2% 96

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sphera Funds Management's VYGR Position: Q1 2026 in Review

Sphera Funds Management increased its Voyager Therapeutics (VYGR) stake by 38% in Q1 2026, buying an estimated $512K and bringing the position to 469,761 shares worth $1.81M. The position accounts for 0.29% of the portfolio, ranked #82.

Sphera Funds Management first reported a position in VYGR in Q3 2025 and has held it in 3 quarters since. 135 funds tracked by Wall St. Rank hold VYGR as of Q1 2026.

  • Sphera Funds Management held 469,761 shares of Voyager Therapeutics worth $1.81M as of Q1 2026.
  • Sphera Funds Management bought 130,000 Voyager Therapeutics shares in Q1 2026, an estimated $512K.
  • Voyager Therapeutics made up 0.29% of Sphera Funds Management's portfolio in Q1 2026, its #82 holding.
  • Sphera Funds Management first reported a position in Voyager Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2026.

Based on Sphera Funds Management's 13F filing for Q1 2026, filed 15 May 2026.